Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Discov. 2011 Jun;1(1):23-4. doi: 10.1158/2159-8274.CD-11-0069. Epub 2011 Apr 14.

A new target for therapy in squamous cell carcinoma of the lung.

Author information

1
Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.

Abstract

Investigators report the identification of novel somatic mutations in the DDR2 kinase gene in squamous cell carcinoma of the lung. Cellular, biochemical, and human data suggest that tumor cells harboring DDR2 mutations have increased sensitivity to existing tyrosine kinase inhibitors, providing rationale for clinical trials of agents that inhibit DDR2 kinase in the disease.

PMID:
22586316
DOI:
10.1158/2159-8274.CD-11-0069
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center